Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2012; 58(1): 93-101

NF-kB activation under metabolic syndrome

I.P. Kaidashev

    Higher State Educational Establishment of Ukraine“Ukrainian Medical Stomatological Academy”, Poltava.


The paper examines the formation of evolutionary advanced causal factors set in modern conditions which may cause new pathological condition (state), being implemented through evo­lutionary fixed and standard pathological processes. The analysis of the notion of “metabolic syndrome” and its components has been performed. The correlation between insulin resistance, chronic inflammation, arterial hypertension, endothelial dysfunction and dyslipidemia has been indicated as the manifestations of one pathologic process, the central molecular basis of which is the activation of NF-kB. At the current stage it has been suggested to set up the conception of NF-kB permanent (long-lasting, low grade) activation as a possible model of pathological process.

Keywords: metabolic syndrome, insulin resistance, NF-kB.


  1. Альперн Д.Е. Патологическая физиология. - М. : Медицина, 1965. - 434 с.
  2. Берштейн Л.М., Коваленко И.Г. “Метаболически здоровые” лица с ожирением и метаболические признаки ожирения у лиц с нормальной массой тела: что за этим стоит? // Пробл. эндокринологии. - 2010. -№3 -С. 47-51.
  3. Зайчик А.Ш., Чурилов Л.П. Основы общей патологии. Часть 1. Основы общей патофизиологии. -СПб. :ЭЛБИ, 1999. - 624 с.
  4. Ізмайлова О.В., Шликова О.А., Боброва И.О., Кайдашев І.П. Зв’язок поліморфізмів генів TLR2 та TLR4 зі схильністю до окремих урогенітальних інфекцій // Цитология и генетика. - 2011. - № 4. -С.29-35.
  5. Патологическая физиология / Под ред. чл.-корр. АМН СССР Н.Н. Зайко. - К.: Вища школа, 1985. - 575 с.
  6. Abdul-Ghani M.A., Jenkinson C.P., Richardson D.K., Tripathy D., DeFronzo R.A. Insulin secretion and ac­tion in subjects with impaired fasting glucose and im­paired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VAGES) // Diabetes. - 2006. - 55. - P. 1430-1435.
  7. Alberti K., Zimmer P. Definition, diagnosis and classification of Diabetes mellitus and its complications, part1: diagnosis and classification of diabetes mellitus, provisional report of a World Health Organization consultation // Diabet. Med. - 1998. - 15. - P. 539-553.
  8. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C Harmonizing the metabolic syndrome: a joint interim statement of the Interna­tional Diabetes Federation Task Force on Epidemiol­ogy and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. - 2009. - 120. - P. 1640-1645.
  9. 9. Alberti K.G., Zimmer P., Shaw J. IDF Epidemiology Task Force Consensus Group. The Metabolic Syn­drome -a new worldwide definition // Lancet. - 2005. -366. - P. 1059-1062.
  10. 10. Bajaj M., DeFronzo R.A. Metabolic and molecular basis of insulin resistance // J. Nucl. Cardiol. - 2003. -10. - P. 311-323.
  11. Bays H., Mandarino L., De Fronzo R.A. Role of the adipocytes, FFA, and ectopic fat in the pathogenesis of type 2 diabetes mellitus: PPAR agonists provide a rational therapeutic approach // J. Clin. Endocrinol. Metab. - 2004. - 89. - P. 463-478.
  12. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications // Amer. J. Cardiol. -2002. - 21. - P. 40L-48L.
  13. Coletta D.K., Balas B., Chavez A.O., Baig M., Abdul-Ghani M., Kashyap S.R., Folli F., Tripathy D., Mandarino L.J., Cornell J.E., Defronzo R.A., Jenkinson C.P. Effect of acute physiological hyperin-sulinemia on gene expression in human skeletal muscle in vivo // Amer. J. Physiol. Endocrinol. Metab. - 2008. -294. - P. E910-E917.
  14. De Alvaro C, Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappa B kinase in a p38 mark-dependent manner // J. Biol. Chem. - 2004. - 279. - P. 17070-17078.
  15. De Fronzo R. A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis : the missing links. The Claude Bernard lecture 2009 // Diabetologia. - 2010. -53. - P.1270-1287.
  16. Del Prato S., Leonetti F., Simonson D.C. Effect of sus­tained physiologic hyperinsulinaemia and hypergly-caemia on insulin secretion and insulin sensitivity in man // Ibid. - 1994. - 37. - P. 1025-1035.
  17. Folli F., Bouchie J.L., Kahn C.R., Hansen H., Feener E.P. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels // J. Clin. Invest. -1997. - 100. - P. 2158-2169.
  18. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex // J. Biol. Chem. - 2002. - 277. - P. 48115-48121.
  19. 19. Garg R., Tripathy D., Dandona P. Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions // Curr. Drug Targets. - 2003. -4. – P. 487-492.
  20. 20. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C. Jr., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm R.H. Jr., Probsteld J.L., SimonsMorton D.G., Friedewald W.T. Effects of in­tensive glucosae lowering in type 2 diabetes // N. Engl. J. Med. - 2008. - 358. - P. 2345-2359.
  21. Golovchenko I., Goalstone M.L., Watson P., Brownlee M., Draznin B. Hyperinsulinemia Enhances Transcrip­tional Activity of Nuclear Factor-kB Induced by An­giotensin II, Hyperglycemia, and Advanced Glyco­sylation End Products in Vascular Smooth Muscle Cells // Circulat. Res. - 2000. - 87. - P. 746-762.
  22. Grundy S. M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syn­drome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement // Cir­culation. - 2005. - 112. - P. 2735-2752.
  23. Gulli G., Ferrannini E., Stern M., Haffner S., DeFronzo R.A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents // Diabetes. - 1992. - 41. - P. 1575-1586.
  24. Holman R.R., Thorne K.I., Farmer A.J., Davies M.J., Keenan J.F., Paul S., Levy J.C. Addition of Biphasic, Pran­dial, or Basal Insulin to Oral Therapy in Type 2 Diabetes // N. Engl. J. Med. - 2007. - 357. - P. 1716-1730.
  25. Kashyap S., Belfort R., Berria R., Suraamornkul S., Pratipranawatr T., Finlayson J., Barrentine A., Bajaj M., Mandarino L., DeFronzo R., Cusi K. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes // Amer. J. Physiol. Endocrinol. Metab. - 2004. - 287. - P. E537-E546.
  26. Kaydashev I.P., Rasin A.M., Shlykova O.A., Gorbas’ I.M., Smirnova I.P., Petrushov A.V., Rasin M.S. Fre­quency of Pro12Ala-Polymorphism of the Gene PPARr2 in the Ukrainian Population and Its Possible Relation to the Development of the Metabolic Syndrome // Cytol. and Genet. - 2007. - 41, № 5. - P.298-302.
  27. Miranda P.J., DeFronzo R.A., Califf R.M., Guyton J.R. Metabolic syndrome: evaluation of pathological and therapeutic outcomes // Amer. Heart J. - 2005. -149. - P. 20-45.
  28. Naruse K., Shimizu K., Muramatsu M., Toki Y, Miyazaki Y, Okumura K., Hashimoto H., Ito T. Long-term inhibi­tion of NO synthesis promotes atherosclerosis in the hy-percholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation // Arterioscler Thromb. - 1994. - 14. - P. 746-752.
  29. 29. National Cholesterol Education Program (NCEP) Ex­pert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detec­tion, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report // Circulation. - 2002. - 106. - P. 3143-3421.
  30. 30. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kB signaling pathway // Nat. Immunol. - 2011. -12 (8). - P. 695-708
  31. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D.E., Hamet P., Harrap S., Heller S., Liu L.S., Mancia G. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes // New Engl. J. Med. - 2008. - 358. - P. 2560-2725.
  32. Reaven G. M. Banting Lecture 1988. Role of insulin resistance in human disease // Diabetes. - 1988. - 37. -P. 1594-1607.
  33. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic sundrome // Trends Endocrinol. Metab. - 2003. - 14. - P. 398-403.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.